Summary
Bloomberg Tech Europe’s ‘Future of Health’ special examines how wearables, full-body scanners, and AI are converging to shift healthcare from reactive treatment to proactive prevention. The episode features in-depth conversations with Oura Health chief medical officer Ricky Bloomfield, Hilo CEO Stefan Petzinger, Neko Health co-founder and CEO Hjalmar Nilsson, and investors from SV Health. Bloomfield outlines clinical programs already underway — including a sleep apnea detection initiative with Medicare Advantage plan Essence — and previews cardiovascular age estimation via pulse wave velocity as a near-term Oura feature. Bloomberg reports Oura could be valued above $6 billion at a forthcoming Nasdaq debut.
Neko Health’s Nilsson demonstrates full-body scanning technology using color, 3D, and thermal cameras to track moles, body composition, and cardiovascular risk factors within minutes. Across the interviews, AI emerges as the connective tissue: executives describe it as uniquely suited to synthesizing sleep, activity, and blood pressure data into holistic insights that fragmented specialist care cannot replicate — while also flagging the hallucination risk and the continuing need for a human clinical layer.
The global wearable tech market is projected to grow from $103 billion today to $230 billion by 2033, giving the episode significant business and investment context alongside the technology discussion. Viewers interested in how AI is being deployed in consumer health devices and what health tech leaders believe it can — and cannot — yet do reliably will find substantive, first-hand perspective throughout.
📺 Source: Bloomberg Tech · Published September 11, 2026
🏷️ Format: Interview
